checkAd

     177  0 Kommentare Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock - Seite 3

    Contact

    Intra-Cellular Therapies, Inc.
    Juan Sanchez, M.D.
    Vice President, Corporate Communications and Investor Relations
    646-440-9333

    Media Inquiries:

    Burns McClellan, Inc.
    Cameron Radinovic
    cradinovic@burnsmc.com
    212-213-0006

    Lesen Sie auch

     



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock - Seite 3 NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) - Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) …